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Recent case reports suggest a possible causal correlation between antecollis and pramipexole.
Here, we report the case of a 62-year-old Italian man with a 2-year history of Parkinson’s
disease (PD) and cervical spondylosis for which he was treated with pramipexole. He devel-
oped severe neck rigidity immediately after an inguinal hernia operation but several months
after introduction of pramipexole. He was initially treated with painkillers and physiotherapy with
no significant improvement. His condition deteriorated presenting disproportionate rigidity
between anterior and posterior neck muscles (antecollis) to the extent that normal activities
were severely restricted. However, significant improvement occurred after the withdrawal of pra-
mipexole. The patient undertook a second cycle of physiotherapy with remarkable results and
returned to function normally in everyday life. This case report suggests that neurologists
should be motivated to inform the scientific community about other possible cases in which an
association between antecollis and pramipexole might operate in PD.
INTRODUCTION
Parkinson’s disease (PD) is an idiopathic progressive
neurological condition associated with degeneration of
dopaminergic neurons in the substantia nigra, resulting in
dopamine loss in the striatum. Prevalence statistics vary
widely but a meta-analysis of US and European studies
suggests 1% of those aged over 65 suffer from the
disease [1]. Common motor deﬁcits (bradykinesia, muscle
rigidity and tremor) typically improve with dopaminergic
replacement therapy.
Pramipexole is a dopamine receptor agonist used to treat
PD, particularly in its early stages. A number of studies have
indicated continued efﬁcacy of the treatment for up to 4 years
while identifying potentially severe side effects such as
dyskinesia, asymptomatic orthostatic hypotension and nausea
[2, 3]. A small number of recent PD cases have identiﬁed a
possible link between pramipexole and the development of
antecollis (marked neck ﬂexion, disproportionate to trunk
ﬂexion) with recovery apparently contingent upon the with-
drawal of treatment [4, 5].
CASE REPORT
A 62-year-old Italian man developed slowness and loss of
strength of his right arm and hand. In July 2010, after a ﬁrst
neurological examination, he was prescribed L-DOPA,
250 mg/day, resulting in signiﬁcant improvement of his par-
kinsonism. PD was therefore indicated using an ex juvantibus
reasoning. Subsequent magnetic resonance imaging carried
out in October 2010 excluded other conditions. At this point,
the diagnosis of PD was conﬁrmed and the neurologist who
followed the patient at that time made the decision to change
treatment to 1.05 mg/day of pramipexole and the complete
cessation of L-DOPA. He was checked twice over a period of
12 months and his condition was considered stable each time.
The patient had a history of cervical spondylosis, a very
common condition in the aging population caused by the pro-
gressive degeneration of the neck bones and neck tissues. He
also had a straightforward inguinal hernia for which he under-
took a corrective operation on 21 November 2011. The oper-
ation started at 9:00 am and ended at 9:30 am. He did not take
pramipexole on the day of the operation. Given the option of
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general anesthesia or epidural he chose the former, carried out
as follows:
– Stage 1: Analgesic administration: [ultiva (remifentanil);
infusion pumps were used]
– Stage 2: Anesthesia induction: (propofol and curare imme-
diately after)
– Stage 3: Intubation: [halogenated anesthetic (sevorane)];
– Stage 4: Before wake up: prostigmina was used to eliminate
curare and sevorane was stopped.
There were no postoperative complications and the patient
was discharged on the same day. He restarted taking prami-
pexole (1.05 mg) on the morning after the operation. On the
same day, he developed neck rigidity and his head dropped
forward. The local general practitioner treated him with pain-
killers, but these proved ineffective.
From the immediate onset of antecollis the patient’s life
was severely impaired: he needed assistance at work, could
not drive his car and experienced difﬁculties when eating and
speaking. On 3 April 2012, the patient decided to consult a
professional physiotherapist who objectively conﬁrmed severe
antecollis: his neck was bent forward at an angle of 80–908.
He could actively extend his head up only of about 50–408
with obvious compensation of the posterior and inferior
(lumbar) muscles of the vertebral trunk. Therefore, this was
not a real extension of the head and could not be sustained
beyond 30 s. The neck rotation on both left and right sides
of the head was severely restricted. He undertook 10 physio-
therapy sessions with the aim of reducing the strong contrac-
tion of his neck muscles. However, no improvement was
observed on treatment completion.
In June 2012, 6 months from the onset of antecollis, follow-
ing similar cases reported in the literature [4, 5], it was
decided to withdraw pramipexole and reintroduce L-DOPA.
The improvement was almost immediate: on the ﬁrst day, the
patient felt less pressure on the neck and gained more ﬂexibil-
ity. After a few days, he could easily turn his neck and he
started to drive his car again.
On 13 August 2012, about 2 months after the cessation of
pramipexole, the patient decided to undertake a second cycle
of physiotherapy. His condition objectively appeared signiﬁ-
cantly improved, despite the extended period of time in which
his neck movements were severely impaired. The only change
in his treatment regime from June to August 2012 was the ces-
sation of pramipexole.
Since this second cycle of physiotherapy, neck angle
remained about 308 at rest. The patient can now perform ex-
tension and rotation movement easily, as shown in Fig. 1.
Unlike the cited cases in which antecollis appeared within a
few weeks after taking pramipexole, this patient developed
antecollis several months after its introduction for the treat-
ment of PD. This relatively extended period might indicate
that some factor(s) other than pramipexole may have induced
antecollis, but the improvement upon cessation suggests other-
wise. Intriguingly, antecollis emerged immediately after the
inguinal hernia operation, raising the possibility that onset
was triggered by the surgical procedure—however, this inter-
pretation is highly speculative.
DISCUSSION
We report the case of a PD patient who received 1-year
treatment with pramipexole with no evident side effects, and
developed antecollis after an inguinal hernia operation.
Physiotherapy did not improve the condition, and ultimately a
decision was implemented to cease pramipexole and reintro-
duce L-DOPA. This change of medication improved his ante-
collis and allowed him to return to his normal life habits. The
patient had a history of cervical spondylosis but had never suf-
fered from muscle rigidity before PD was diagnosed or
between diagnosis and his hernia operation.
Claims for a relationship between antecollis and pramipex-
ole have been reported in the literature [4, 5]. In this case
report, however, the connection is complicated by the
extended delay between the introduction of pramipexole and
the onset of antecollis. Nevertheless, the antecollis showed
dramatic improvement once pramipexole was withdrawn.
Moreover, we tentatively raise the possibility that anesthesia
(in this case prior to an inguinal hernia operation) might inter-
act in some way with pramipexole to encourage the onset of
antecollis. However, given the rate at which the effects of
general anesthetics abate and the chemicals are ‘washed-out’,
a viable explanation for such a link is difﬁcult to envisage.
The neck positioning during intubation could also have played
a role. However, we suggest that this is unlikely given the
short duration of the surgical procedure (30 min).
In conclusion, further investigation is needed to determine
with conﬁdence the relationship between pramipexole and
antecollis in PD. This case report suggests that neurologists
should be motivated to inform the scientiﬁc community about
other possible cases of PD in which an association between
antecollis and pramipexole might operate.
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Figure 1: A 62-year-old patient with Parkinson’s disease who developed
antecollis following treatment with pramipexole (1.05 mg/day) showing: (A)
prominent antecollis in an upright position during treatment with pramipexole
and (B) improvement of antecollis after withdrawal of the pramipexole
treatment.
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